Annabel Mcmillan

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma patients and myeloma healthcare professionals.

Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma patients and myeloma healthcare professionals.

Journal: Frontiers in oncology

Published: June 30, 2025

Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group.

Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group.

Journal: British journal of haematology

Published: April 08, 2025

Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.

Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.

Journal: EJHaem

Published: September 10, 2024

Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience.

Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience.

Journal: Haematologica

Published: August 06, 2024

Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.

Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.

Journal: EJHaem

Published: April 03, 2024

The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma-a single-centre, qualitative service evaluation study.

The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma-a single-centre, qualitative service evaluation study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: October 05, 2023

Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.

Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.

Journal: Leukemia & lymphoma

Published: June 01, 2023

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.

Journal: British journal of haematology

Published: November 13, 2022

Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.

Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.

Journal: Leukemia & lymphoma

Published: May 16, 2022

Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma.

Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma.

Journal: Haematologica

Published: April 28, 2022

Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice.

Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice.

Journal: Cytometry. Part B, Clinical cytometry

Published: April 18, 2022

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Journal: British journal of haematology

Published: October 11, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026